Indegene (INDGN) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Indegene's AGM approved strategic growth plans, dividend increase, and AI-focused expansion in life sciences.

🔄 What Changed
Revenue grew to INR3,500 crores with EBITDA of INR6,247 million; dividend raised to INR2.25/share; BioPharm acquisition integrated contributing 21.5% of prior revenue; client base expanded with 91 active customers and net revenue retention above 100%.

🔮 What's Next
Target 19%-20% EBITDA margins by Q4 2027; expand USD75M+ client base; pursue acquisitions in clinical, regulatory, and commercialization spaces; maintain capex at ~1% of revenue; achieve 30-40% YoY growth in ECS segment.

💡 Investor Takeaway
Indegene is positioning itself as an AI-powered leader in life sciences with profitable growth ambitions, but margin pressure from investments requires monitoring of execution and acquisition integration.

Indegene Limited held its 28th AGM on August 13, 2026, showcasing strategic growth in AI-driven life sciences services, with FY25-'26 revenue of INR3,500 crores and EBITDA of INR6,247 million. The company announced a final dividend of INR2.25 per share and plans to expand high-value client segments, targeting USD75M+ contracts and 19%-20% EBITDA margins by 2030. Strategic acquisitions like BioPharm (INR882 crores) support its vision amid a USD2 trillion market opportunity.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Appointment of Ms. Jill Mary De Simone as Independent Director approved at AGM

🔄 What Changed
New Independent Director appointed with three-year term effective January 22, 2026

🔮 What's Next
Term extends until January 21, 2029

💡 Investor Takeaway
The appointment strengthens the board with experienced biopharmaceutical leadership for strategic oversight.

Indegene announced the appointment of Ms. Jill Mary De Simone as an Independent Director approved by shareholders at the 28th AGM held on August 13, 2026. Her term begins January 22, 2026 and spans three years until January 21, 2029. The filing confirms no related party relationships and compliance with SEBI regulations.

3 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
All resolutions passed at 28th AGM with majority approval

🔄 What Changed
Shareholder approval of director appointments and remuneration package

💡 Investor Takeaway
Shareholders approved all agenda items, signaling confidence in management continuity.

Indegene Limited announced the results of its 28th Annual General Meeting held on August 13, 2026, where all proposed resolutions were passed with requisite majority, confirming shareholder approval of key corporate actions including director appointments and remuneration.

📊 Stock Analysis — INDGN ✨ Ask AI About This

About Indegene Limited (INDGN)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹14,746.4 Cr P/E: 36.6 ROE: 12.8% ROCE: 17.4% Div Yield: 0.37%

View full INDGN stock details →

📡 Get AI alerts when INDGN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDGN — Free

💡 Ask AI about this filing

"How will BioPharm integration affect long-term margins?" "What is the timeline for achieving 19-20% EBITDA margins?" "How many USD75M+ clients does Indegene aim to acquire by 2030?"

Ask AI Free →

📊 More INDGN filings

See all INDGN filings →

🔥 Also filed on 17 August 2026

PREMIERENE Premier Energies Limited Announcement ABCAPITAL Aditya Birla Capital Limited Corporate Action VIVIMEDLAB Vivimed Labs Limited Announcement GSPCROP GSP Crop Science Limited Financial Results SEDEMAC SEDEMAC Mechatronics Limited Annual Report AFFLE Affle 3i Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDGN files new disclosures

Track INDGN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDGN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Indegene Limited (INDGN) — Board Meeting | 17 August 2026(3 announcements)

About Indegene Limited (INDGN)

📡 Get AI alerts when INDGN files next

💡 Ask AI about this filing

📊 More INDGN filings

🔥 Also filed on 17 August 2026